At a glance
Toro Labs Retatrutide is a next-generation triple agonist peptide acting on GIP, GLP-1 and glucagon receptors simultaneously, at the forefront of metabolic research, precision dosed at 30mg per vial. HPLC tested and authenticated on every batch.
Official re-seller for Toro Labs
Key details
- 30mg lyophilised peptide, single vial
- Triple receptor agonist: GIP, GLP-1, glucagon
- Batch tested via HPLC analysis
- Toro Labs authenticated product
Research benefits
- Studied for body weight and fat mass reduction
- Superior metabolic outcomes vs dual agonists
- Supports blood glucose and insulin sensitivity
- May improve lipid profiles and cardiovascular markers
Suggested protocol
- Starting dose 0.5mg to 2mg per week
- Subcutaneous administration
- Gradual titration recommended in research settings
- Reconstitute with bacteriostatic water before use
About Retatrutide 30mg
Retatrutide 30mg is a synthetic triple receptor agonist peptide, supplied as a lyophilised powder. It carries a strength of 30mg. It is part of the Toro Labs range, our own house brand, and Express Peds is an official re-seller. Ordered before 2pm Monday to Friday it is dispatched the same day from the UK, sent Royal Mail Tracked 24 in plain unbranded packaging.
